Lavietox D Project Re Set Purifying Softner
NDC Package 70374-0002-1
Package Information
Lavietox D Project Re Set Purifying Softner is a . Marketed by Aqualex, this product is identified by NDC 70374-0002 and is authorized under FDA application M016.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70374 - Aqualex
- 70374-0002 - Lavietox D Project Re Set Purifying Softner
- 70374-0002-1 - 100 mL in 1 BOTTLE
- 70374-0002 - Lavietox D Project Re Set Purifying Softner
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70374-0002-1 identifies a specific commercial package of 100 ml in 1 bottle of Lavietox D Project Re Set Purifying Softner, labeled by Aqualex. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Aqualex on December 25, 2015. The current certification is valid through December 31, 2016.
How is this Aqualex product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70374000201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.